Current Pattern of Psychiatric Comorbidity and Psychotropic Drug Prescription in Child and Adolescent Patients

dc.authoriddemirci, begum/0000-0001-7490-3366
dc.authoridARAZ ALTAY, MENGUHAN/0000-0001-9433-050X
dc.contributor.authorAltay, Menguhan Araz
dc.contributor.authorBozatli, Leyla
dc.contributor.authorSipka, Begilm Demirci
dc.contributor.authorGorker, Isik
dc.date.accessioned2024-06-12T10:56:15Z
dc.date.available2024-06-12T10:56:15Z
dc.date.issued2019
dc.departmentTrakya Üniversitesien_US
dc.description.abstractBackground: In recent years, patterns of the use of psychotropic drugs vary with increasing rates of psychiatric presentation and diagnosis in children and adolescents. Purpose: In this study, we aimed to investigate distributions of current psychiatric symptoms and diagnosis, patterns of the use of psychotropic drugs, and differences according to age and gender in patients presented to a child and adolescent outpatient clinic. Methods: All patients aged between 0 and 18 years presenting to a child and adolescent psychiatry outpatient clinic between November 1, 2017 and November 1, 2018 were included in the study. Files of all patients were examined in detail, and patients' demographic characteristics, symptoms, psychiatric diagnoses established according to the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), psychotropic drugs initiated, and side effect profiles were recorded. Psychiatric symptoms and diagnostic features of the patients were determined, and the differences were investigated according to gender. Clinical characteristics were compared between diagnosed and undiagnosed patients, and between patients with and without drug initiation. Results: Of the 2066 patients, 1298 (62.8%) were male and the mean age was 10.14 +/- 4.42 years. The most common symptoms were hyperactivity (23.8%) and inattention (21.6%) in males, inattention (15.1%) and irritability (14.2%) in females, and 79% of the patients received one or more psychiatric diagnoses. The most common psychiatric diagnoses in both genders were attention-deficit hyperactivity disorder (ADHD), specific learning disorder (SLD), and conduct disorder, respectively. Of the patients who received a psychiatric diagnosis, 61.8% were using psychotropic drugs, with the majority of them (71.3%) receiving monotherapy. The most frequently initiated drugs included psychostimulants, antipsychotics, and antidepressants, with 28.7% of the drug user patients receiving multiple drug therapy. Conclusion: Our study indicates that rate of presentation to child and adolescent psychiatry outpatient clinics is increasing, and rates of diagnosis and initiation of psychiatry drugs are high among the presented children. The prevalence of ADHD shows an increase in males and females in our country, and psychiatric polypharmacy has reached significant rates.en_US
dc.identifier.doi10.3390/medicina55050159
dc.identifier.issn1010-660X
dc.identifier.issn1648-9144
dc.identifier.issue5en_US
dc.identifier.pmid31108992en_US
dc.identifier.scopus2-s2.0-85066430132en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.urihttps://doi.org/10.3390/medicina55050159
dc.identifier.urihttps://hdl.handle.net/20.500.14551/19720
dc.identifier.volume55en_US
dc.identifier.wosWOS:000472666200044en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherMdpien_US
dc.relation.ispartofMedicina-Lithuaniaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectChild And Adolescent Psychiatryen_US
dc.subjectOutpatient Treatmenten_US
dc.subjectSymptomsen_US
dc.subjectDSM-5en_US
dc.subjectPsychotropic Medicationen_US
dc.subjectMental-Health-Careen_US
dc.subjectTrendsen_US
dc.subjectDisordersen_US
dc.subjectAdultsen_US
dc.subjectAdhden_US
dc.subjectPrevalenceen_US
dc.subjectChecklisten_US
dc.subjectSymptomsen_US
dc.subjectAutismen_US
dc.titleCurrent Pattern of Psychiatric Comorbidity and Psychotropic Drug Prescription in Child and Adolescent Patientsen_US
dc.typeArticleen_US

Dosyalar